Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
Filetype[PDF-613.68 KB]


  • Supporting Files:
    No Additional Files
This document has replaced (most recent first):
  1. Protection against viral hepatitis : recommendations of the Immunization Practices Advisory Committee (ACIP)
    Corporate Authors:
    Centers for Disease Control (U.S.). Centers for Disease Control (U.S.). Immunization Practices Advisory Committee..
    Published Date:
    February 9, 1990
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1990; 39(RR-2):1-26.
    Description:
    The following statement updates all previous recommendations on protection against viral hepatitis, including use of hepatitis B vaccine and hepatitis B immune globulin for prophylaxis of hepatitis B (MMWR 1985;34:313-24,329-35 and MMWR 1987,36:353-6...
    Status:
    superseded
    File Type:
    Filetype[HTML]
  2. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Vaccines Work Group.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    December 23, 2011
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 60, no. no. 50, p. 1709-11
    Description:
    Hepatitis B virus (HBV) causes acute and chronic infection of the liver leading to substantial morbidity and mortality. In the United States, since 1996, a total of 29 outbreaks of HBV infection in one or multiple long-term-care (LTC) facilities, inc...
    Status:
    superseded
    File Type:
    Filetype[PDF - 3.23 MB]
  3. Hepatitis B virus : a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)
    Corporate Authors:
    Centers for Disease Control (U.S.). Immunization Practices Advisory Committee.. National Center for Infectious Diseases (U.S.). Division of Viral Hepatitis..
    Published Date:
    November 22, 1991
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1991; 40(RR-13):1-25.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 40, no. RR-13
    Description:
    The following statement updates all previous recommendations on protection against hepatitis B virus infection, including use of hepatitis B vaccine and hepatitis B immune globulin for prophylaxis against hepatitis B virus infection (MMWR 1985;34:313...
    Status:
    superseded
    File Type:
    Filetype[PDF - 23.85 MB]
  4. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
    Corporate Authors:
    National Center for Infectious Diseases (U.S.). Division of Viral Hepatitis.
    Published Date:
    December 23, 2005
    Source:
    MMWR. Morbidity and mortality weekly report. 1987; 36(23):353-60, 366.
    Description:
    This report is the first of a two-part statement from the Advisory Committee on Immunization Practices (ACIP) that updates the strategy to eliminate hepatitis B virus (HBV) transmission in the United States. The report provides updated recommendation...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1012.35 KB]
  5. Prevention of perinatal transmission of hepatitis B virus : prenatal screening of all pregnant women for hepatitis B surface antigen
    Corporate Authors:
    National Center for Infectious Diseases (U.S.). Division of Viral Hepatitis.
    Published Date:
    June 10, 1988
    Source:
    MMWR. Morbidity and mortality weekly report. 1988; 37(22):341-6, 351.
    Description:
    In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged > or =2 years. In 2005, vaccine manufacturers received Food and Drug Ad...
    Status:
    retired
    File Type:
    Filetype[HTML]
  6. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management
    Personal Author:
    Schillie, Sarah F.; Murphy, Trudy V.; Sawyer, Mark; Ly, Kathleen; Hughes, Elizabeth; Jiles, Ruth; de Perio, Marie A.; Reilly, Meredith; Byrd, Kathy; Ward, John W.;
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). National Institute for Occupational Safety and Health.. United States. Advisory Committee on Immunization Practices..
    Published Date:
    December 20, 2013
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, no. RR-10
    Description:
    This report contains CDC guidance that augments the 2011 recommendations of the Advisory Committee on Immunization Practices (ACIP) for evaluating hepatitis B protection among health-care personnel (HCP) and administering post-exposure prophylaxis. E...
    Status:
    superseded
    File Type:
    Filetype[PDF - 712.51 KB]
You May Also Like:
  1. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending August 1, 2020 (Week 31) Table1q Hepatitis B, perinatal infection; Hepatitis C (viral, acute)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    08/06/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 31
    Description:
    2020-31-Table1q -H.pdf
    File Type:
    Filetype[PDF - 113.87 KB]
  2. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending July 25, 2020 (Week 30) Table1q Hepatitis B, perinatal infection; Hepatitis C (viral, acute)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    07/31/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 30
    Description:
    2020-30-Table1q -H.pdf
    File Type:
    Filetype[PDF - 113.89 KB]
  3. Progress Toward Hepatitis B Control — South-East Asia Region, 2016–2019
    Personal Author:
    Sandhu, Hardeep S.; Roesel, Sigrun; Sharifuzzaman, Mohammad; Chunsuttiwat, Supamit; Tohme, Rania A.;
    Published Date:
    July 31 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(30):988-992
    Description:
    In 2015, the World Health Organization (WHO) South-East Asia Region (SEAR)* reported an estimated 40 million persons living with chronic hepatitis B virus (HBV) infection and 285,000 deaths from complications of chronic infection, cirrhosis, and hepa...
    File Type:
    Filetype[PDF - 300.60 KB]
  4. Evaluation of Online Risk Assessment To Identify Rabies Exposures Among Health Care Workers — Utah, 2019
    Personal Author:
    Whitehouse, Erin R.; Peterson, Dallin; McCaffrey, Keegan; Eichenbaum, Amit; Gruninger, Randon; Dascomb, Kristin K.; Frame, Cherie; Wallace, Ryan; Bonwitt, Jesse;
    Published Date:
    July 24 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(29):956-959
    Description:
    On November 7, 2018, the Utah Department of Health (UDOH) reported the first confirmed human rabies death in the state since 1944 (1). The case occurred in a person who had been treated over a period of 19 days at four health care facilities and an e...
    File Type:
    Filetype[PDF - 100.11 KB]
  5. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending July 18, 2020 (Week 29) Table1q Hepatitis B, perinatal infection; Hepatitis C (viral, acute)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    07/23/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 29
    Description:
    2020-29-Table1q -H.pdf
    File Type:
    Filetype[PDF - 114.39 KB]